Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 847.60
-6.35 (-0.74%)
At close: Sep 4, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 210.03 billion as of September 4, 2026. Its market cap has increased by 67.09% in one year.
Market Cap
210.03B
Enterprise Value
215.81B
Revenue
56.32B
Ranking
n/a
PE Ratio
31.45
Stock Price
847.60
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 210.03B, an increase of 128,203.33%. That is a compound annual growth rate of 35.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 210.03B | 44.60% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 549.90B |
| GlaxoSmithKline Pharmaceuticals | 501.20B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 213.61B |
| AstraZeneca Pharma India | 173.27B |
| Jubilant Pharmova | 146.31B |
| Viyash Scientific | 115.84B |
| Procter & Gamble Health | 93.92B |